Related Experiment Video
Updated: May 13, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
GEO combined with quantitative protein trait loci identify causative proteins in hypertrophic cardiomyopathy
1Department of Endocrinology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China.
Insights
This study identified two proteins, carbonic anhydrase 3 (CA3) and serpin family E member 1 (SERPINE1), causally linked to hypertrophic cardiomyopathy (HCM). These findings offer potential new biomarkers and therapeutic targets for this rare genetic heart disease.
Area of Science:
- Cardiovascular Genetics
- Proteomics
- Rare Diseases
Background:
- Hypertrophic cardiomyopathy (HCM) is a rare genetic heart condition with limited research and treatment options.
- Identifying novel therapeutic targets and biomarkers is crucial for managing HCM.
- Integrating multi-omics data offers a powerful approach to uncover disease-associated mechanisms.
Purpose of the Study:
- To identify proteins causally associated with hypertrophic cardiomyopathy (HCM).
- To leverage integrated analysis of cardiac gene expression and proteomic data.
- To explore potential therapeutic targets and diagnostic markers for HCM.
Main Methods:
- Analysis of Gene Expression Omnibus (GEO) cardiac tissue datasets (GSE36961, GSE180313) from HCM patients and controls.
- Integration with protein quantitative trait locus (pQTL) data from UK Biobank.
- Genome-wide association study (GWAS) data from the FinnGen study for HCM.
- Two-sample Mendelian randomization (MR) analysis to assess causal relationships.
- Sensitivity analyses for heterogeneity and horizontal pleiotropy.
Main Results:
- Two proteins, carbonic anhydrase 3 (CA3) and serpin family E member 1 (SERPINE1), were identified as causally associated with HCM risk.
- Both CA3 and SERPINE1 showed a significant association with increased odds of developing HCM.
- Analyses confirmed no significant heterogeneity or horizontal pleiotropy, supporting the robustness of the findings.
Conclusions:
- CA3 and SERPINE1 proteins demonstrate a potential causal role in the development of HCM.
- These proteins may serve as valuable characteristic markers for HCM diagnosis.
- CA3 and SERPINE1 represent promising targets for future therapeutic interventions in HCM.
Aims:
Hypertrophic cardiomyopathy (HCM) is a rare genetic heart disease characterized by a limited patient population and scarce research and treatment resources. This study aimed to identify HCM-associated proteins by integrating cardiac tissue data from the Gene Expression Omnibus (GEO) database with the latest protein quantitative trait locus (pQTL) dataset.
Methods And Results:
We analysed data from the GEO database. The GSE36961 dataset included 106 HCM samples and 39 healthy controls. The GSE180313 dataset included 13 HCM samples and 7 healthy controls. pQTL data were obtained from the plasma of 54 000 UK Biobank participants, covering 1463 proteins. HCM genome-wide association study (GWAS) data were sourced from the FinnGen study, which included 1125 HCM cases and 411 056 controls. We analysed the GEO dataset of cardiac tissue from HCM patients to identify differentially expressed genes (DEGs). These DEGs were compared with pQTL data to identify protein phenotypes suitable for Mendelian randomization (MR) analysis. A two-sample MR analysis was performed to assess the causal association between these protein phenotypes and HCM. The robustness of the study results was further assessed through sensitivity analysis of heterogeneity and horizontal pleiotropy tests. Two proteins were identified as causally associated with HCM risk: carbonic anhydrase 3 (CA3) [inverse variance weighted (IVW): odds ratio (OR) = 1.292, 95% confidence interval (CI) = 1.021-1.636, P = 0.033] and serpin family E member 1 (SERPINE1) [IVW: OR = 1.313, 95% CI = 1.063-1.621, P = 0.011]. Both proteins were associated with increased HCM risk, with no significant heterogeneity (P > 0.05) or evidence of horizontal pleiotropy (P > 0.05).
Conclusions:
CA3 and SERPINE1 proteins may exert causal effects on HCM and may serve as characteristic markers and therapeutic targets for this condition.
Related Concept Videos
Pleiotropy
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

